Type I interferons (IFN), such as interferon-alpha (IFN-α), and proinflammatory cytokines such as tumor necrosis factor-alpha (TNF-α) play an important role in the pathogenesis and disease progression of systemic lupus erythematosus (SLE) [1]. This evidence concerns the gene IFNA1 and systemic lupus erythematosus.